Summary In order to identify potential markers of prognosis in breast cancer, representative cDNA libraries were constructed using RNA isolated from primary breast tumour tissue associated with good and poor prognosis. Cross-screening of these libraries repeatedly identified cloned mRNA species associated with the immune system, in particular B-cells, in libraries derived from tumours of poor prognosis. We have used one of these, a KIV light chain cDNA probe, in two complementary studies to investigate the relationship between immunoglobin gene expression and prognosis. The results obtained using a combination of S, mapping, RNA blotting and in situ hybridisation demonstrate that the presence of plasma cells, as defined by infiltrating cells which express high levels of immunoglobulin K-chain mRNA, is associated with a poor prognosis.
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A large proportion of women with operable primary breast cancer have occult micrometastases at presentation. The most accurate indicator of the presence of metastases is the extent of axillary lymph node involvement assessed by a pathologist after complete axillary dissection. However the introduction of breast conservation has reduced axillary dissections and the prognostic information derived from the determination of nodal involvement. This has led to a search for useful prognostic markers of metastases present within the primary tumour tissue such as histological grade (Richardson & Bloom, 1957) , steroid receptor proteins , milk fat globule antigens (Wilkinson et al., 1984) , neu oncogene expression (Slamon et al., 1987) and cell surface glycoproteins (Leatham & Brooks, 1987) . However, none of these markers is sufficiently accurate for clinical use, and new, more precise markers of prognosis would be of great value in order to plan appropriate treatments, and for the psychological management of the patient and her family.
In a series of experiments designed to identify novel markers of poor prognostic significance we constructed large cDNA libraries in bacteriophage AgtI0 using poly(A)-containing RNA isolated from primary breast tumour tissue associated with good and poor prognosis. Cross-screening of these libraries tepeatedly identified mRNA sequences associated with the immune system, in particular B-cells, in the cDNA library constructed from poor prognosis tumour tissue, suggesting a potential correlation between the presence of infiltrating cells of the immune system and poor prognosis. Here we describe S, mapping, RNA blotting and in situ hybridisation studies using a cloned human immunoglobulin light K-chain cDNA hybridisation probe. These provide evidence that the presence of plasma cells, as defined by infiltrating cells producing high levels of immunoglobulin K-chain mRNA, is associated with poor prognosis in primary mammary carcinoma.
Materials and methods
Reagents [oL-32P] (1985) . Cross-screening of the cDNA libraries using 32P-labelled cDNA was carried out at low density (1-2x 103pfu/9 cm plate) using the hybridisation conditions described by Benton & Davis (1977) . Individual differentially expressed recombinant phage plaques were picked, amplified in liquid culture, and cDNA inserts excised and subcloned directly into the EcoRI site of pUC 13 using procedures described by Maniatis et al. (1982) . EcoRI excised inserts from this subclone were then ligated into M13 vectors (MplO, Mpll) for DNA sequence analysis (Sanger et al., 1977) and Si mapping experiments. Inserts were also recloned into Gemini vectors (pGEM 1, pGEM 2) for preparation of RNA transcripts for in situ hybridisation.
RNA blotting and S1 mapping Analysis of poly(A)-containing RNA by RNA blotting was carried out as described by Taylor et al. (1984) . Probes were labelled with [a32P]dCVP by nick translation (Rigby et al., 1977) . S, mapping experiments were performed employing conditions modified from Berk & Sharp (1977) , using a single stranded 32P-labelled M13 DNA probe, prepared essentially as described by Myers et al. (1985) . Hybridisation reactions were incuba$ed at 52°C for 18h, and Si nuclease digestion was at 37°C for 1 h. Protected fragments were analysed by electrophoresis on 6% (w/v) polyacrylamide urea gels.
In situ hybridisation
Tumour blocks were sectioned (5yu) on a microtome and sections layered onto clean, sterile, poly-L-lysine coated glass slides (Huang et al., 1983) . These were baked at 37°C overnight prior to storage at room temperature in a dry, dust-free box. Sections stored in this manner have been successfully used over a period of 6 months. Prior to use sections were dewaxed by sequential immersion of slides in xylene, followed by stepwise rehydration through alcohol.
Further pre-treatment of sections prior to in situ hybridisation, was performed as detailed by Hoefler et al. (1986) .
Radiolabelled sense and anti-sense RNA probes were synthesised from HindlIl linearised pGEM 1 (cRNA) and pGEM 2 (mRNA) constructs, by incorporation of [x-32P]CTP into transcripts from the T7 promoter, as modified by Promega (technical bulletin) from Melton et al. (1984) . RNA probe (4 ng), corresponding to 2 x 106 cpm, was applied to each section in 20,pl hybridisation buffer. Hybridisation was performed as described by Hoefler et al. (1986) . After washing and dehydration, the slides were coated in Ilford liquid nuclear track emulsion (K5), dried and exposed at 4°C in light-tight boxes for 2-10 days. Slides were developed at 20°C in Kodak D19 developer, and fixed in 5% (w/v) sodium thiosulphate. Sections were counterstained with haematoxylin and eosin prior to microscopic examination.
Results
Identification Of K-mRNA in RNA preparations from primary breast carcinoma We have constructed a number of representative AgtIO cDNA libraries (2-3 x 106 recombinants) from poly(A)-containing RNA isolated from primary breast carcinomas containing oestrogen and progesterone receptors or no receptors, and from primary breast carcinomas which on the criteria of size, grade, lymph node involvement, extracellular HMFG staining, and receptor status, are indicative of good or bad prognosis (see Table I ). Direct cross-screening of these libraries with 32P-labelled cDNA probes using strategies to identify cloned mRNA species prevalent for example in the tumour of potentially bad as opposed to good prognosis, repeatedly resulted in the identification of immunoglobulin K-light and y-heavy chain mRNA sequences, data consistent with the view that there was significant infiltration by B-cells of the 'poor' prognosis tumour relative to that of 'good' prognosis (Collis, 1988) .
In order to investigate the possibility that levels of immunoglobulin mRNA expression might prove a useful prognostic factor, we have used one of these cloned sequences (phZH2) as a hybridisation probe to quantitate and localise the site of immunoglobulin mRNA expression in breast cancer. The cloned cDNA inserted in phZH2 ( Figure  1 ) comprises a 256 bp fragment of K light chain mRNA, containing an open reading frame, encoding part of the variable region (Vk), J-region (Jk) and part of the constant region (Ck). Comparison of the deduced amino acid sequence with other available K-chain amino sequences in the Vk regions demonstrated amino acid sequence homology with K subgroup IV (see Klobeck et al., 1985; Marsh et al., 1985) . We have used this KiV cDNA sequence, recloned into (1984) . We took ECS to be a good prognostic feature. appropriate vectors, to investigate by RNA blotting, S1 mapping and in situ hybridisation the relative levels, and site of synthesis of K-chain mRNA in RNA isolated from primary breast carcinomas, which, on a number of criteria (see Table I ) were predicted to be of 'good' or 'bad' prognosis. This selection was found later to be reasonably accurate since on follow up all the tumours with features of a poor prognosis have resulted in relapse in all patients and death in 4 out of 5 within 32 months, whereas those with features of a good prognosis are alive 30-40 months after mastectomy, of which only one has relapsed (see Table I ).
Initially the levels of K-chain mRNA expressed in tumour RNA were assessed by RNA (Northern) blotting relative to actin mRNA in a small group of tumours. Total poly(A)-containing RNA was separated on the basis of size by gel electrophoresis, blotted onto Biodyne membranes and coprobed with 32P-labelled phZH2 and pAM-91 (actin) cDNA probes. A typical result (Figure 2 ), demonstrates the presence of an intense band of the expected size of K-chain mRNA (11OOntds) in three RNA preparations all from tumours of bad prognosis, the presence of the same band in the control tonsil RNA preparation, and the presence of low levels only of K-chain mRNA in the two good prognosis tumours examined in this instance. The actin mRNA (1600ntds) was present at approximately equivalent levels in all RNA preparations.
In order to increase the sensitivity of our analyses, conserve RNA, and to determine the relative level of expression of K,1 mRNA to total K-mRNA, we have performed Si mapping using a 327 ntd uniformly 32p_ polylinker sequence, and sequence encoding VkIV, Jk and Ck (see Figure 3AI ). The results ( Figure 3BI ) compare K-mRNA levels in poly(A)-containing RNA isolated from five bad prognosis, and five good prognosis tumours (see Table I ) with RNA from a tonsil (positive control), benign breast and normal breast. In the tonsil control track, a number of diffuse protected bands are apparent, the two most prominent being of 183 and 175ntds, representing complete protection of the Ck and Jk region of the probe, and limited S, nuclease digestion of part of the 5' end of the Jk region respectively. This was expected taking into account J region duplication (Hieter et al., 1982) and junctional variation during V-J recombination (Weigert et al., 1980 Figure 3AII) , the relative levels of Tcell receptor f-chain mRNA (Collins et al., 1985) , an equivalent marker for T cells. The results (Figure 3B11 ), using the same RNA samples used for K-mRNA analysis, show the expected protected T cell receptor mRNA band of 479 ntds in the tonsil RNA preparation, identifying the presence of T cell receptor mRNA. The protected band was barely discernible in the benign and normal breast RNA preparations, and of the remainder, only in one 'good' prognosis RNA preparation were T cell receptor mRNA levels significantly increased (2-3-fold) compared with normal breast. Analysis of T cell receptor mRNA levels in RNA preparations from bad prognosis tumours, showed a small 2-3-fold increase, and in one instance a 10-15-fold increase in T cell receptor mRNA levels relative to normal breast. Overall T cell receptor mRNA levels were elevated in tumour tissue, but there was no particular bias between good and bad prognosis tumour RNA preparations.
Retrospective analysis of K-mRNA expression by in situ hybridisation The results described above on a relatively small number of clinically well defined breast tumour preparations, provide evidence for increased infiltration of primary breast tumours, where the prognosis is poor, by cells of the immune system, in particular B cells. The approach whilst revealing, is time consuming, too complex for the routine pathology laboratory, and inappropriate for retrospective studies where available material is limited to formalin fixed paraffin embedded blocks. We have therefore employed in situ hybridisation using 32P-labelled K-chain cRNA hybridisation probes to identify K-mRNA producing cells in paraffin embedded formalin fixed tissue sections. Initially the validity of the technique was established using tonsil, rapidly processed post-operatively. As can be seen the morphology of the section is retained in spite of prolonged hybridisations (Figure 4a) Figure 4 -Identification of cells expressing immunoglobulin Kchain mRNA by in situ hybridisation. Immunoglobulin K-chain cDNA cloned in phZH2 (256bp) was subcloned into pGEMl and pGEM2, and used to generate 32P-labelled cRNA and mRNA hybridisation probes as described in Materials and methods. These were then used for in situ hybridisation to (a) human tonsil (cRNA), (b) human tonsil (mRNA), (c) poor prognosis primary breast carcinoma -PB78 (cRNA), and (d) PB60 -good prognosis primary breast carcinoma (cRNA). Sections were exposed for 48h. Figure 5 Comparison of the maximum number of immunoglobulin K-chain producing cells present in a 2.6mm2 field of view as judged by in situ hybridisation (see Figure 4 , and text) in sections from 1 1 year old formalin-fixed paraffin embedded primary breast carcinoma tissue from patients now deceased or still surviving (see Tables IIA, B) . Exposure time was 48 h.
patients, hybridisation was undetectable in 14 sections and in only one instance was hybridisation apparent, in this instance to numerous single cells ( Figure 5 ). In contrast, of the 19 blocks examined from patients now deceased, three showed no detectable K-mRNA producing cells, whilst the remainder had positive cell counts ranging from 12 to 800 cells within the optimum field of view ( Figure 5 ). Prolonged exposure (5-7 days) identified a second population of cells to which the probe hybridised weakly. Cell counts of this population showed no significant bias towards either the 'good' or 'bad' prognosis groupings. The in situ experiments described above have also been performed using a A light chain constant region cRNA probe. These results confirmed our observations using the Kchain cRNA probe, but in addition, provided evidence that the ratio of plasma cells producing K as opposed to A light chain mRNA was unexpectedly high (4.5: 1), when compared with the expected ratio (2: 1) which we have found in normal tissue by in situ hybridisation.
Discussion
We have demonstrated using complementary but independent approaches that the presence of elevated levels of immunoglobulin K-chain mRNA in breast tumour tissue is associated with poor prognosis. In particular, that cells enriched in K-chain mRNA infiltrate tumours of 'poor' as opposed to 'good' prognosis.
Lymphoplasmacytic infiltration within tumours has been studied extensively and, according to the early literature, was generally thought to be a favourable prognostic sign. A review of earlier work (Underwood, 1974) reported that in 8 studies, five showed a correlation between cell infiltration and 'good' prognosis, whereas three were negative. Since that time there have been numerojis additional conflicting rerports of associations between infiltration and for example favourable prognosis (Black et al., 1975; Dawson et al., 1982; Stenkvist et al., 1982) , and poor prognosis (Roses et al., 1982; Fisher et al., 1983) . However, a consistent theme in more recent studies has been the association of lymphoplasmacytic infiltration and histological features of poor prognosis such as poor grade, nuclear pleomorphism, tumour necrosis and lymph node invasion by tumour (Black et al., 1975; Lauder et al., 1977; Fisher et al., 1983; von Kleist et al., 1987; Zuk & Walker, 1987 Schoorl et al., 1976; Hsu et al., 1981; Hurlimann & Soraga, 1985; Lwin et al., 1985; von Kleist et al., 1987; Zuk & Walker, 1987 (1985) report that B cells can represent up to 48% of the total number of T cells, whilst Zuk and Walker (1987) provide evidence that the proportion of B cells increase relative to T cells in carcinoma as opposed to benign breast, with an overall B:T cell ratio as high as 1:2.
In all studies the prognostic significance of T cell subpopulation and B cell distribution was unclear.
Our study on ten primary breast tumours representative of 'good' and 'bad' prognosis (see Table I Analysis of the distribution of plasma cells in archival, paraffin embedded formalin-fixed tissue, using blocks prepared without special precautions from tumours removed from patients operated upon over ten years earlier, provided data which confirmed and extended the data generated via a detailed molecular analysis of K-chain mRNA levels and localisation in the ten selected tumours of potentially 'good' and 'bad' prognosis. In this study, plasma cells were found in tumours from 84% of women who had relapsed and died, whereas only in one of the tumours (6%) from women who survived 10 years or more were plasma cells detected. It is of interest that the single tumour in the group of survivors in which plasma cell infiltration was considerable, was a medullary carcinoma, a tumour type associated with 'good' prognosis (Ridolfi et al., 1977) with characteristic lymphoplasmacytic infiltration (Hsu et al., 1981) .
Clinically our studies would suggest that the presence of plasma cells in infiltrating duct carcinoma and mixed infiltrating duct and lobular carcinoma is associated with a poor prognosis. It would also appear, in agreement with previous studies (Ridolfi et al., 1979; Hsu et al., 1981) that plasma cells are present in medullary carcinoma of the breast, and that in these tumours the presence of plasma cells does not reflect a 'poor' prognosis.
Technically our studies emphasise the potential value of in situ hybridisation in routine pathology, and demonstrate that data may be generated after a period of 10 years from tissue fixed and embedded without special precautions to eliminate nuclease degradation of mRNA. The technology described in this paper relies on short-half life 32P-labelled cRNA as the hybridisation probe. However, since the K-chain mRNA is highly abundant in plasma cells and therefore well within the detection limits of non-radiolabelled biotin-streptavidin and similar detection systems, the development of nonradiolabelled K-chain cRNA hybridisation probes suitable for bulk synthesis and therefore routine use would not appear to be an insuperable objective. The use of defined hybridisation probes also should eliminate much conflicting evidence obtained from similar clinical studies obtained using antisera of differing specificity, and in addition, overcome problems associated with the use of monoclonal antibodies on formalin fixed paraffin sections. A larger more detailed study to determine whether plasma cell infiltration is a true independent prognostic factor or whether it is related to other histological features of prognosis in mammary tumours would now be of value. Such a study should include for comparison a parallel analysis of B and T cell markers using a panel of monoclonal antibodies.
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